Scientists routinely use cell lines as healthy and diseased tissue models within drug development. They are easy to maintain, a stable platform and relatively inexpensive. However, they often do not reflect what is physiologically relevant in vivo. This is where primary cells may be a more advantageous choice for complex physiological disease and now an integral platform within Immuno-Oncology Research.
Venue: Web Event (Webinar)
Organiser Contact Details: